Impact Factor 4.155
2017 JCR, Clarivate Analytics 2018

Frontiers journals are at the top of citation and impact metrics

Original Research ARTICLE Provisionally accepted The full-text will be published soon. Notify me

Front. Chem. | doi: 10.3389/fchem.2019.00261

Synthesis, Biological Evaluation and Molecular Modeling Studies of New Thiadiazole Derivatives as Potent P2X7 Receptor Inhibitors

  • 1Universidade Estadual da Zona Oeste UEZO, Brazil
  • 2Fundação Oswaldo Cruz (Fiocruz), Brazil
  • 3Universidade Federal Fluminense, Brazil
  • 4Federal University of Rio de Janeiro, Brazil
  • 5Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Brazil

Thiadiazole analogs synthesis has used azole as the core skeleton to develop P2X7 receptor (P2X7R) inhibitors. Pyrazole and 1,3,4-thiadiazole cores junction formed twenty new lead compound. P2X7R inhibition in vitro was evaluated in mice peritoneal macrophages, HEK-293 transfected with hP2X7R (EtBr uptake assay) and THP-1 cells (IL-1β ELISA assay). The thiadiazole derivatives 9b, 9c, 9f, and 11c, showed potent inhibitory effects with IC50 values ranging from 16 to 122 nM to reduced P2X7R-mediated dye uptake and 20 to 300 nM to IL-1β release. Besides, the in vitro absorption, distribution, metabolism, excretion, and toxicity (ADMET) profile of the four more potent derivatives were determined to be in acceptable ranges concerning metabolic stability and cytotoxicity. Molecular docking and molecular dynamics simulations studies of the molecular complexes human P2X7R/9f and murine P2X7R/9f indicated the putative intermolecular interactions. The compound 9f showed affinity mainly to Arg268, Lys377 and Asn266 residues. These results suggest that thiadiazole derivatives may be promising novel P2X7R inhibitors for the development of anti-inflammatory drugs.

Keywords: P2X7 receptor, Molecular docking., IL-1β release, Paw edema, dye uptake, Thiadiazole, Pyrazole

Received: 21 Jan 2019; Accepted: 01 Apr 2019.

Edited by:

Simone Brogi, University of Pisa, Italy

Reviewed by:

Andrei I. Khlebnikov, Tomsk Polytechnic University, Russia
Björn Rissiek, Department of Neurology, University Medical Center Hamburg-Eppendorf, Germany
William N. Setzer, University of Alabama in Huntsville, United States  

Copyright: © 2019 Gonzaga, Oliveira, Salles, Bello, Rodrigues, Castro, de Souza, Reis, Leme, Mafra, Pinheiro, Hoelz, Boechat and FARIA. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Dr. ROBSON X. FARIA, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Curitiba, Brazil,